Show simple item record

The Interaction of Atovaquone with the P. carinii Cytochrome bc 1 Complex

dc.contributor.authorMeshnick, Steven R.en_US
dc.contributor.authorBerry, Edward A.en_US
dc.contributor.authorNett, Jurgenen_US
dc.contributor.authorKazanjian, Powelen_US
dc.contributor.authorTrumpower, Bernarden_US
dc.date.accessioned2012-08-09T14:57:09Z
dc.date.available2012-08-09T14:57:09Z
dc.date.issued2001-06en_US
dc.identifier.citationMeshnick, Steven R. ; Berry, Edward A. ; Nett, Jurgen ; Kazanjian, Powel ; Trumpower, Bernard (2001). "The Interaction of Atovaquone with the P. carinii Cytochrome bc 1 Complex." Journal of Eukaryotic Microbiology 48: 169s-171s. <http://hdl.handle.net/2027.42/92453>en_US
dc.identifier.issn1066-5234en_US
dc.identifier.issn1550-7408en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/92453
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleThe Interaction of Atovaquone with the P. carinii Cytochrome bc 1 Complexen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michiganen_US
dc.contributor.affiliationotherLawrence Berkeley National Laboratoryen_US
dc.contributor.affiliationotherDartmouth Medical Schoolen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/92453/1/j.1550-7408.2001.tb00505.x.pdf
dc.identifier.doi10.1111/j.1550-7408.2001.tb00505.xen_US
dc.identifier.sourceJournal of Eukaryotic Microbiologyen_US
dc.identifier.citedreferenceAlbers, B., D. Bray, J. Lewis, M. Raff, K. Roberts, and J.D. Watson. 1989 Molecular biology of the cell, 2nd ed., Garland Publishing, Inc., New York. 1219.en_US
dc.identifier.citedreferenceBerry, E.A., M. Guergova‐Kuras, L.S. Huang, and A.R. Crofts. 2000. Structure and function of cytochrome be complexes. Annu Rev Biochem 69: 1005 – 75.en_US
dc.identifier.citedreferenceEsposti, M.D., S. De Vries, M. Crimi, A. Ghelli, T Patarnello, and A. Meyer. 1993. Mitochondriai cytochrome b: evolution and structure of the protein. Biochim Biophys Acta 1143: 243 – 71.en_US
dc.identifier.citedreferenceFry, M. and M. Pudney. 1992. Site of action of the antimalarial hydroxynaphthoquinone, 2‐[trans‐4‐(4'‐chlorophenyl) cyclohexyl]‐3‐hydroxy‐l,4‐naphthoquinone (566C80). Biochem Pharmacol 43: 1545 – 53.en_US
dc.identifier.citedreferenceHunte, C., J. Koepke, C. Lange, T. Rossmanith, and H. Michel. 2000. Structure at 2.3 A resolution of the cytochrome bc(l) complex from the yeast saccharomyces cerevisiae co‐crystallized with an antibody Fv fragment. Structure Fold Des 8: 669 – 84.en_US
dc.identifier.citedreferenceIttarat, I., W. Asawamahasakda, M.S. Bartlett, J.W. Smith, and S.R. Meshnick. 1995. Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase. Antimicrob Agents Chemother 39: 325 – 8.en_US
dc.identifier.citedreferenceKazanjian, P., W. Armstrong, P.A. Hossler, L. Huang, C.B. Beard, J Carter, L. Crane, J. Duchin, W. Burman, J. Richardson, and S.R. Meshnick. 2001. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. J Infect Dis 183: 819 – 22.en_US
dc.identifier.citedreferenceKorsinczky, M., N Chen, B. Kotecka, A. Saul, K Rieckmann, and Q Cheng. 2000. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug‐binding site Antimicrob Agents Chemother 44: 2100 – 8.en_US
dc.identifier.citedreferenceKraulis, P.J. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures J. Appl. Cryst. 24: 946 – 950.en_US
dc.identifier.citedreferenceLooareesuwan, S., C. Viravan, H.K. Webster, D.E. Kyle, D.B. Hutchinson, and C.J. Canfield. 1996. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54: 62 – 6.en_US
dc.identifier.citedreferenceMcFadden, D.C., S. Tomavo, E.A. Berry, and J.C. Boothroyd. 2000. Characterization of cytochrome b from Toxoptasma gondii and Q(o) domain mutations as a mechanism of atovaquone‐resistance. Mol Biochem Parasitol 108: 1 – 12.en_US
dc.identifier.citedreferenceMerritt, E.A. and D.J. Bacon. 1997. Raster3D: Photorealistic Molecular Graphics. Meth. Enzymol. 277: 505 – 524.en_US
dc.identifier.citedreferenceSpencer, C.M. and K.L. Goa. 1995. Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections. Drugs 50: 176 – 96.en_US
dc.identifier.citedreferenceSrivastava, I.K., J.M. Morrisey, E. Darrouzet, F. Daldal, and A.B. Vaidya. 1999. Resistance mutations reveal the atovaquone‐binding domain of cytochrome b in malaria parasites. Mol Microbiol 33: 704 – 11.en_US
dc.identifier.citedreferenceSyafruddin, D., J.E. Siregar, and S. Marzuki. 1999. Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone. Mol Biochem Parasitol 104: 185 – 94.en_US
dc.identifier.citedreferenceWalker, D.J., A.E Wakefield, M.N. Dohn, R.F. Miller, R.P Baughman, P.A. Hossler, M.S. Bartlett, J.W. Smith, P. Kazanjian, and S.R. Meshnick. 1998. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J Infect Dis 178: 1767 – 75.en_US
dc.identifier.citedreferenceZhang, Z., L. Huang, V.M. Shulmeister, Y.I. Chi, K.K. Kim, L.W. Hung, A.R. Crofts, E.A. Berry, and S.H. Kim. 1998. Electron transfer by domain movement in cytochrome bc1 Nature 392: 677 – 84.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.